Role of Reactive Oxygen Species in Tumor Necrosis Factor-alpha Induced Endothelial Dysfunction.

Endothelial cell injury and dysfunction are the major triggers of pathophysiological processes leading to cardiovascular disease. Endothelial dysfunction (ED) has been implicated in atherosclerosis, hypertension, coronary artery disease, vascular complications of diabetes, chronic renal failure, insulin resistance and hypercholesterolemia. Although now recognized as a class of physiological second messengers, reactive oxygen species (ROS) are important mediators in cellular injury, specifically, as a factor in endothelial cell damage. Uncontrolled ROS production and/or decreased antioxidant activity results in a deleterious state referred to as 'oxidative stress'. A candidate factor in causing ROS production in endothelial cells is tumor necrosis factor alpha (TNF-α), a pleiotropic inflammatory cytokine. TNF-α has been shown to both be secreted by endothelial cells and to induce intracellular ROS formation. These observations provide a potential mechanism by which TNF-α may activate and injure endothelial cells resulting in ED. In this review, we focus on the relationship between intracellular ROS formation and ED in endothelial cells or blood vessels exposed to TNF-α to provide insight into the role of this important cytokine in cardiovascular disease.

[1]  V. Kosma,et al.  Hyaluronan in Breast Cancer: Correlations With Nitric Oxide Synthases and Tyrosine Nitrosylation , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[2]  G. Dusting,et al.  Important Role of Nox4 Type NADPH Oxidase in Angiogenic Responses in Human Microvascular Endothelial Cells In Vitro , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Jian-Mei Li,et al.  Nox2 regulates endothelial cell cycle arrest and apoptosis via p21cip1 and p53. , 2007, Free radical biology & medicine.

[4]  S. Felix,et al.  Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells. , 2007, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[5]  D. Eichler,et al.  Tumor necrosis factor-α reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells , 2007 .

[6]  Yun-jie Wang,et al.  Tanshinone IIA inhibits endothelin-1 production in TNF-α-induced brain microvascular endothelial cells through suppression of endothelin-converting enzyme-1 synthesis , 2007, Acta Pharmacologica Sinica.

[7]  A. Feldman,et al.  TNF-&agr; Contributes to Endothelial Dysfunction by Upregulating Arginase in Ischemia/Reperfusion Injury , 2007 .

[8]  A. Petry,et al.  NOX5 variants are functionally active in endothelial cells. , 2007, Free radical biology & medicine.

[9]  Baohua Yang,et al.  TNF-α potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells , 2007 .

[10]  J. Ouyang,et al.  N-acetylcysteine attenuates TNF-alpha-induced human vascular endothelial cell apoptosis and restores eNOS expression. , 2006, European journal of pharmacology.

[11]  T. Kietzmann,et al.  NOX2 and NOX4 mediate proliferative response in endothelial cells. , 2006, Antioxidants & redox signaling.

[12]  S. Pervaiz,et al.  TNF receptor superfamily‐induced cell death: redox‐dependent execution , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  T. Rabelink,et al.  TNF-α induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-γ agonist pioglitazone , 2006 .

[14]  Jie Wang,et al.  Proteomic analysis effects of ginsenoside Rg1 on human umbilical vein endothelial cells stimulated by tumor necrosis factor-alpha. , 2006, Life sciences.

[15]  L. Azevedo,et al.  Redox mechanisms of vascular cell dysfunction in sepsis. , 2006, Endocrine, metabolic & immune disorders drug targets.

[16]  G. Angelini,et al.  Superoxide auto-augments superoxide formation and upregulates gp91(phox) expression in porcine pulmonary artery endothelial cells: inhibition by iloprost. , 2006, European journal of pharmacology.

[17]  P. Neumann,et al.  Peroxynitrite mediates TNF-α-induced endothelial barrier dysfunction and nitration of actin , 2006 .

[18]  C. Szabó,et al.  Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol , 2006, Pharmacological Reviews.

[19]  L. Kuo,et al.  Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles. , 2006, Journal of molecular and cellular cardiology.

[20]  H. Billert,et al.  Regulation of eNOS expression in HCAEC cell line treated with opioids and proinflammatory cytokines. , 2006, Kardiologia polska.

[21]  E. Clementi,et al.  Endothelial Nitric Oxide Synthase Activation by Tumor Necrosis Factor α Through Neutral Sphingomyelinase 2, Sphingosine Kinase 1, and Sphingosine 1 Phosphate Receptors: A Novel Pathway Relevant to the Pathophysiology of Endothelium , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[22]  L. Kuo,et al.  TNF-&agr; Contributes to Endothelial Dysfunction in Ischemia/Reperfusion Injury , 2005 .

[23]  A. Shah,et al.  NADPH oxidase and endothelial cell function. , 2005, Clinical science.

[24]  T. Mukherjee,et al.  The role of reactive oxygen species in TNFα-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells , 2005 .

[25]  S. Ibayashi,et al.  NAD(P)H Oxidases in Rat Basilar Arterial Endothelial Cells , 2005, Stroke.

[26]  M. Christie,et al.  Acute Tumor Necrosis Factor Alpha Signaling via NADPH Oxidase in Microvascular Endothelial Cells: Role of p47phox Phosphorylation and Binding to TRAF4 , 2005, Molecular and Cellular Biology.

[27]  Q. Yao,et al.  TNF-alpha induces interleukin-8 and endothelin-1 expression in human endothelial cells with different redox pathways. , 2005, Biochemical and biophysical research communications.

[28]  E. Tremoli,et al.  Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells. , 2005, Cardiovascular research.

[29]  P. Hordijk,et al.  Expression and localization of NOX2 and NOX4 in primary human endothelial cells. , 2005, Antioxidants & redox signaling.

[30]  G. Schulze-Tanzil,et al.  Redox regulation of apoptosis by members of the TNF superfamily. , 2005, Antioxidants & redox signaling.

[31]  G. Wang,et al.  Exogenous NADPH Increases Cerebral Blood Flow Through NADPH Oxidase–Dependent and –Independent Mechanisms , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[32]  G. Angelini,et al.  Nitroaspirins and Morpholinosydnonimine but Not Aspirin Inhibit the Formation of Superoxide and the Expression of gp91phox Induced by Endotoxin and Cytokines in Pig Pulmonary Artery Vascular Smooth Muscle Cells and Endothelial Cells , 2004, Circulation.

[33]  E. Schiffrin,et al.  Reactive oxygen species in vascular biology: implications in hypertension , 2004, Histochemistry and Cell Biology.

[34]  A. Shah,et al.  Free radicals and redox signalling in cardiovascular disease , 2004, Heart.

[35]  Y. Hannun,et al.  Acid and neutral sphingomyelinases: roles and mechanisms of regulation. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[36]  S. Ibayashi,et al.  Nox4 as the Major Catalytic Component of an Endothelial NAD(P)H Oxidase , 2004, Circulation.

[37]  H. Sumimoto,et al.  Molecular mechanism for activation of superoxide-producing NADPH oxidases. , 2003, Molecules and cells.

[38]  J. Ross,et al.  TNF-α induced DNA damage in primary murine hepatocytes , 2003 .

[39]  J. Turrens,et al.  Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.

[40]  N. Suttorp,et al.  Rho Protein Inhibition Blocks Cyclooxygenase-2 Expression by Proinflammatory Mediators in Endothelial Cells , 2003, Inflammation.

[41]  A. Takeshita,et al.  Oxidative Stress Mediates Tumor Necrosis Factor-&agr;–Induced Mitochondrial DNA Damage and Dysfunction in Cardiac Myocytes , 2003, Circulation.

[42]  F. Scalera Intracellular glutathione and lipid peroxide availability and the secretion of vasoactive substances by human umbilical vein endothelial cells after incubation with TNF‐α , 2003, European journal of clinical investigation.

[43]  A. Minagar,et al.  TNF-alpha -induced endothelial cell adhesion molecule expression is cytochrome P-450 monooxygenase dependent. , 2003, American journal of physiology. Cell physiology.

[44]  B. Vallet Bench-to-bedside review: Endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? , 2003, Critical care.

[45]  M. Netea,et al.  TNFα AND IL-1β EXERT NO DIRECT VASOACTIVITY IN HUMAN ISOLATED RESISTANCE ARTERIES , 2002 .

[46]  A. Alonso,et al.  Sphingomyelinases: enzymology and membrane activity , 2002, FEBS letters.

[47]  F. Nwariaku,et al.  Involvement of TRAF4 in Oxidative Activation of c-Jun N-terminal Kinase* , 2002, The Journal of Biological Chemistry.

[48]  J. Pober,et al.  Endothelial activation: intracellular signaling pathways , 2002, Arthritis research.

[49]  J. Granger,et al.  TNF-alpha enhances contraction and inhibits endothelial NO-cGMP relaxation in systemic vessels of pregnant rats. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[50]  A. Shah,et al.  Essential Role of the NADPH Oxidase Subunit p47phox in Endothelial Cell Superoxide Production in Response to Phorbol Ester and Tumor Necrosis Factor-&agr; , 2002, Circulation research.

[51]  Justin R. Davis,et al.  Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha-induced hypertension in pregnant rats. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[52]  J. Lambeth,et al.  The neutrophil NADPH oxidase. , 2002, Archives of biochemistry and biophysics.

[53]  Elias S. J. Arnér,et al.  Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. , 2001, Free radical biology & medicine.

[54]  P. Stenvinkel Endothelial dysfunction and inflammation-is there a link? , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[55]  I. Fridovich,et al.  Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. , 2001, Circulation research.

[56]  Tetsuro Ago,et al.  Novel modular domain PB1 recognizes PC motif to mediate functional protein–protein interactions , 2001, The EMBO journal.

[57]  H. Nick,et al.  Tumor Necrosis Factor-α Selectively InducesMnSOD Expression via Mitochondria-to-Nucleus Signaling, whereas Interleukin-1β Utilizes an Alternative Pathway* , 2001, The Journal of Biological Chemistry.

[58]  E Vicaut,et al.  Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide. , 2001, American journal of respiratory cell and molecular biology.

[59]  B. Babior,et al.  Assembly of the neutrophil respiratory burst oxidase: A direct interaction between p67PHOX and cytochrome b558 II , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[60]  B. Babior,et al.  Assembly of the neutrophil respiratory burst oxidase: A direct interaction between p67PHOX and cytochrome b558 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[61]  G. Bokoch,et al.  Molecular basis for Rac2 regulation of phagocyte NADPH oxidase , 2001, Nature Immunology.

[62]  B. Fanburg,et al.  Reactive oxygen species in cell signaling. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[63]  N. Koide,et al.  Augmentation of Nitric Oxide Production by Gamma Interferon in a Mouse Vascular Endothelial Cell Line and Its Modulation by Tumor Necrosis Factor Alpha and Lipopolysaccharide , 2000, Infection and Immunity.

[64]  J. Aasly,et al.  Cytokine enhancement of endothelin ET(B) receptor-mediated contraction in human temporal artery. , 2000, European journal of pharmacology.

[65]  E. Wagner TNF-α induced bronchial vasoconstriction , 2000 .

[66]  K. Irani,et al.  Rac1 inhibits TNF‐α‐induced endothelial cell apoptosis: dual regulation by reactive oxygen species , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  S. Frøland,et al.  Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines , 2000, Clinical transplantation.

[68]  Hiroshi Yamamoto,et al.  The Receptor for Advanced Glycation End Products Is Induced by the Glycation Products Themselves and Tumor Necrosis Factor-α through Nuclear Factor-κB, and by 17β-Estradiol through Sp-1 in Human Vascular Endothelial Cells* , 2000, The Journal of Biological Chemistry.

[69]  N. Chandel,et al.  Cellular oxygen sensing by mitochondria: old questions, new insight. , 2000, Journal of applied physiology.

[70]  Tetsuro Ago,et al.  Mechanism for Phosphorylation-induced Activation of the Phagocyte NADPH Oxidase Protein p47 phox , 1999, The Journal of Biological Chemistry.

[71]  P. Iversen,et al.  Human cytokines modulate arterial vascular tone via endothelial receptors , 1999, Pflügers Archiv.

[72]  S. Chatterjee Neutral sphingomyelinase: past, present and future. , 1999, Chemistry and physics of lipids.

[73]  M. Luster,et al.  Tumor Necrosis Factor a and Toxicology , 1999 .

[74]  F. Inagaki,et al.  Tetratricopeptide Repeat (TPR) Motifs of p67 phox Participate in Interaction with the Small GTPase Rac and Activation of the Phagocyte NADPH Oxidase* , 1999, The Journal of Biological Chemistry.

[75]  J. Lambeth,et al.  The p67 phox Activation Domain Regulates Electron Flow from NADPH to Flavin in Flavocytochromeb 558 * , 1999, The Journal of Biological Chemistry.

[76]  L. Reece,et al.  Mitochondrial glutathione modulates TNF-α-induced endothelial cell dysfunction , 1999 .

[77]  C. Thompson,et al.  Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death. , 1998, Genes & development.

[78]  M. Takano,et al.  Ambient but not incremental oxidant generation effects intercellular adhesion molecule 1 induction by tumour necrosis factor alpha in endothelium. , 1998, The Biochemical journal.

[79]  G. D. De Keulenaer,et al.  Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. , 1998, The Biochemical journal.

[80]  M. Han,et al.  Overexpression of HSP25 reduces the level of TNFα‐induced oxidative DNA damage biomarker, 8‐hydroxy‐2′‐deoxyguanosine, in L929 cells , 1998, Journal of cellular physiology.

[81]  A. Mantovani,et al.  Endothelial Activation by Cytokines a , 1997, Annals of the New York Academy of Sciences.

[82]  J. Williamson,et al.  TNF-α causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms. , 1997, American journal of physiology. Heart and circulatory physiology.

[83]  M. Matsuo [Oxidative stress and aging]. , 1997, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[84]  N. Kaplowitz,et al.  GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. , 1997, The American journal of physiology.

[85]  A. Nussler,et al.  Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. , 1997, Nitric oxide : biology and chemistry.

[86]  E. Block,et al.  Proinflammatory cytokines downregulate gene expression and activity of constitutive nitric oxide synthase in porcine pulmonary artery endothelial cells. , 1997, Research communications in molecular pathology and pharmacology.

[87]  A. Allison,et al.  Inhibitory effect of di-catechol rooperol on VCAM-1 and iNOS expression in cytokine-stimulated endothelium. , 1996, Life sciences.

[88]  R. Witkamp,et al.  Suppression of cytochrome P450- and UDP glucuronosyl transferase-dependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes. , 1996, Toxicology and applied pharmacology.

[89]  M. Hill,et al.  Endotoxin interacts with tumor necrosis factor-alpha to induce vasodilation of isolated rat skeletal muscle arterioles. , 1996, Shock.

[90]  M. Welsh,et al.  TNF-α potentiates oxidant and reperfusion-induced endothelial cell injury , 1996 .

[91]  D. M. Parker,et al.  TNF-alpha induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. , 1995, The American journal of physiology.

[92]  W. Fiers,et al.  Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[93]  D. Roos,et al.  156Pro-->Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox , 1994, The Journal of experimental medicine.

[94]  R. Janzer,et al.  Tumor cells suppress cytokine‐induced nitric‐oxide (no) production in cerebral endothelial cells , 1994, International journal of cancer.

[95]  B. Ames,et al.  Oxidative damage and mitochondrial decay in aging. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[96]  T. Leto,et al.  Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[97]  C. Mitaka,et al.  Effects of TNF-alpha on hemodynamic changes and circulating endothelium-derived vasoactive factors in dogs. , 1994, The American journal of physiology.

[98]  T Nose,et al.  Role of Src homology 3 domains in assembly and activation of the phagocyte NADPH oxidase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[99]  Z. Ba,et al.  Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. , 1994, The American journal of physiology.

[100]  P. Finan,et al.  An SH3 domain and proline-rich sequence mediate an interaction between two components of the phagocyte NADPH oxidase complex. , 1994, The Journal of biological chemistry.

[101]  G. Baxter,et al.  Effects of tumor necrosis factor on in vitro digital arterial responses in horses. , 1994, American journal of veterinary research.

[102]  T. Kuratsuji,et al.  A novel cytosolic component, p40phox, of respiratory burst oxidase associates with p67phox and is absent in patients with chronic granulomatous disease who lack p67phox. , 1994, Biochemical and biophysical research communications.

[103]  W. Fiers,et al.  Molecular mechanisms of tumor necrosis factor‐induced cytotoxicity , 1994, FEBS letters.

[104]  K. Macnaul,et al.  Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. , 1993, Biochemical and biophysical research communications.

[105]  W. Fiers,et al.  Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene‐inductive effects of TNF. , 1993, The EMBO journal.

[106]  J. Kolls,et al.  Tumor necrosis factor-alpha inhibits endothelium-dependent relaxation. , 1993, Journal of applied physiology.

[107]  D. Rotrosen,et al.  Cytochrome b558: the flavin-binding component of the phagocyte NADPH oxidase. , 1992, Science.

[108]  B. Brenner,et al.  Transcriptional regulation of the endothelin-1 gene by TNF-alpha. , 1992, The American journal of physiology.

[109]  W. Fiers,et al.  Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. , 1992, The Journal of biological chemistry.

[110]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[111]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[112]  P. Ward,et al.  Mediator‐induced activation of xanthine oxidase in endothelial cells , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[113]  A. Gorren,et al.  The reaction of nitric oxide with copper proteins and the photodissociation of copper-NO complexes. , 1987, Biochimica et biophysica acta.

[114]  S. Moncada,et al.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.

[115]  N. Blough,et al.  Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution , 1985 .

[116]  B Chance,et al.  Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.

[117]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[118]  L. Liaudet,et al.  Nitric oxide and peroxynitrite in health and disease. , 2007, Physiological reviews.

[119]  D. Eichler,et al.  Tumor necrosis factor-alpha reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells. , 2007, American journal of physiology. Heart and circulatory physiology.

[120]  Baohua Yang,et al.  TNF-alpha potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells. , 2007, American journal of physiology. Heart and circulatory physiology.

[121]  A. Feldman,et al.  TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[122]  Zhe Zhou,et al.  Cryptotanshinone inhibits endothelin-1 expression and stimulates nitric oxide production in human vascular endothelial cells. , 2006, Biochimica et biophysica acta.

[123]  W. Min,et al.  Endothelial cell dysfunction, injury and death. , 2006, Handbook of experimental pharmacology.

[124]  L. Kuo,et al.  TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[125]  T. Rabelink,et al.  TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone. , 2006, European heart journal.

[126]  P. Neumann,et al.  Peroxynitrite mediates TNF-alpha-induced endothelial barrier dysfunction and nitration of actin. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[127]  J. Ross,et al.  TNF-alpha induced DNA damage in primary murine hepatocytes. , 2003, International journal of molecular medicine.

[128]  D. Kereiakes,et al.  Endothelial dysfunction. , 2003, Circulation.

[129]  A. Vercesi,et al.  Reactive Oxygen Generation by Mitochondria , 2002 .

[130]  W. Dröge Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[131]  M. Netea,et al.  TNFalpha and IL-1beta exert no direct vasoactivity in human isolated resistance arteries. , 2002, Cytokine.

[132]  H. Nick,et al.  Tumor necrosis factor-alpha selectively induces MnSOD expression via mitochondria-to-nucleus signaling, whereas interleukin-1beta utilizes an alternative pathway. , 2001, The Journal of biological chemistry.

[133]  N. Arakawa,et al.  Effects of tumor necrosis factor-alpha on basal and stimulated endothelium-dependent vasomotion in human resistance vessel. , 2000, Journal of cardiovascular pharmacology.

[134]  E. Wagner TNF-alpha induced bronchial vasoconstriction. , 2000, American journal of physiology. Heart and circulatory physiology.

[135]  C. Kupatt,et al.  Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts. , 1999, Circulation research.

[136]  L. Reece,et al.  Mitochondrial glutathione modulates TNF-alpha-induced endothelial cell dysfunction. , 1999, Free radical biology & medicine.

[137]  M. Luster,et al.  Tumor necrosis factor alpha and toxicology. , 1999, Critical reviews in toxicology.

[138]  J. Lambeth,et al.  Regulation of the Neutrophil Respiratory Burst Oxidase IDENTIFICATION OF AN ACTIVATION DOMAIN IN p67 phox * generation by neutrophil , 1998 .

[139]  M. Welsh,et al.  TNF-alpha potentiates oxidant and reperfusion-induced endothelial cell injury. , 1996, The Journal of surgical research.

[140]  J. Vane,et al.  Cytokine Regulation of Endothelin‐1 Release from Bovine Aortic Endothelial Cells , 1995, Journal of cardiovascular pharmacology.

[141]  A. Boveris Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. , 1984, Methods in enzymology.

[142]  M. Billingsley,et al.  Protein Kinase C (cid:1) Regulates Tumor Necrosis Factor- (cid:2) -Induced Stannin Gene Expression , 2022 .

[143]  W. Chilian,et al.  Tumor Necrosis Factor- (cid:1) Induces Endothelial Dysfunction in the Prediabetic Metabolic Syndrome , 2022 .